Literature DB >> 908177

Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens.

R Behin, J Mauel, D S Rowe.   

Abstract

The purpose of this investigation was to determine whether prior induction of a non-specific delayed reaction at a site of leishmanial infection could modify the course of infection. Groups of animals were made hypersensitive to either DNCB or BCG and a delayed reaction was elicited by corresponding antigen in one or both ears when an infective dose of L. enriettii was inoculated. With various experimental designs the following results were obtained: (a) induction of delayed reaction by DNCB or BCG inhibited the development of leishmanial lesions; (a) the protection was effective only when delayed reaction occurred at the site of infection; (c) to be effective, the reaction had to be continuously present at the site of infection for at least 3--4 weeks; (d) lesions developed normally, in the absence of delayed reaction, in DNCB-tolerant animals treated with DNCB; (E) a protective delayed reaction did not completely eliminate the parasites from the host tissues, since metastatic lesions appeared later at ectopic areas; (f) the suppressed development of a lesion did not confer resistance to reinfection dose of the parasite. It is concluded that cell-mediated immunity plays an important role in healing leishmanial lesions in the guinea-pig and that the final effector mechanism may be sought in the non-specific microbicidal capacity of activated macrophages. The relevance of leishmania-specific delayed reaction in the course of the disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908177      PMCID: PMC1541084     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria.

Authors:  J Convit; M E Pinardi; G Rodríguez Ochoa; M Ulrich; J L Avila; M Goihman
Journal:  Clin Exp Immunol       Date:  1974-06       Impact factor: 4.330

2.  Temperature and metabolism in Leishmania. 3. Some dehydrogenases of L. donovani, L. mexicana, and L. tarentolae.

Authors:  J Janovy
Journal:  Exp Parasitol       Date:  1972-10       Impact factor: 2.011

3.  Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity.

Authors:  L Polak; J L Turk
Journal:  Nature       Date:  1974-06-14       Impact factor: 49.962

4.  Immunity in cutaneous leishmaniasis of the guinea-pig.

Authors:  A D Bryceson; R S Bray; R A Wolstencroft; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

5.  The mechanism of tolerance in contact hypersensitivity to dinitrochlorobenzene in guinea-pigs.

Authors:  W J Halliday; B A Walters
Journal:  Clin Exp Immunol       Date:  1974-02       Impact factor: 4.330

6.  Cutaneous leishmaniasis in the guinea pig. Delayed-type hypersensitivity, lymphocyte stimulation, and inhibition of macrophage migration.

Authors:  T M Blewett; D M Kadivar; E J Soulsby
Journal:  Am J Trop Med Hyg       Date:  1971-07       Impact factor: 2.345

7.  Characteristics of so-called natural antibodies in various normal sera against culture forms of Leishmania.

Authors:  G A Schmunis; R Herman
Journal:  J Parasitol       Date:  1970-10       Impact factor: 1.276

Review 8.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

9.  Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. I. Lack of effects of immune lymphocytes and of activated macrophages.

Authors:  J Mauel; R Behin; D S Rowe
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

10.  Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. II. Selective destruction of different Leishmania species in activated guinea-pig and mouse macrophages.

Authors:  R Behin; J Mauel; D S Rowe
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

View more
  9 in total

1.  The kinetics and quality of acquired resistance in self-healing and metastatic leishmaniasis.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

2.  [Suppression of parasitemia in rodent filariasis (Litomosoides carinii) by immunization with BCG and microfilaria. I. Intracutaneous inoculation of BCG].

Authors:  P Kimmig; P Wenk
Journal:  Z Parasitenkd       Date:  1982

3.  Nonspecific immunodepression and protective immunity in mice infected with Leishmania mexicana.

Authors:  H Pérez; M Pocino; I Malavé
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

4.  Mechanisms of immunity to leishmaniasis. II. Significance of the intramacrophage localization of the parasite.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

5.  Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major.

Authors:  M Nasseri; F Z Modabber
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

6.  Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.

Authors:  G F Grimaldi; P L Moriearty; R Hoff
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

7.  The quantification of viable Leishmania enriettii from infected guinea-pig tissues.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

8.  Resolution of cutaneous leishmaniasis after acute eczema due to intralesional meglumine antimoniate.

Authors:  Erica de Camargo Ferreira e Vasconcellos; Maria Inês Fernandes Pimentel; Cláudia Maria Valete-Rosalino; Maria de Fátima Madeira; Armando de Oliveira Schubach
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jul-Aug       Impact factor: 1.846

Review 9.  Leishmaniasis vaccination: targeting the source of infection.

Authors:  S G Reed
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.